Kamonpun Ussavarungsi, Xiaowen Hu, J P Scott, David B Erasmus, Jorge M Mallea, Francisco Alvarez, Augustine S Lee, Cesar A Keller, Jay H Ryu, Charles D Burger
OBJECTIVES: Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease that generally results in progressive decline in lung function. Despite advancement of pharmacological therapy for LAM, lung transplantation remains an important option for women with end-stage LAM. METHODS: Patients with LAM undergoing lung transplantation at the Mayo Clinic campuses in Rochester, Minnesota and Jacksonville, Florida since 1995 were retrospectively reviewed. RESULTS: Overall, 12 women underwent lung transplantation...
October 2015: Respiratory Medicine